Filing Details

Accession Number:
0001213900-22-033077
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-06-15 16:31:04
Reporting Period:
2022-06-14
Accepted Time:
2022-06-15 16:31:04
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
316253 Enzo Biochem Inc ENZ Services-Medical Laboratories (8071) 132866202
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1797876 David Bench C/O Enzo Biochem, Inc.
527 Madison Avenue
New York NY 1002
Chief Financial Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock, $0.01 Par Value Acquisiton 2022-06-14 3,500 $2.15 6,000 No 4 P Indirect By Trust (PSP)
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect By Trust (PSP)
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock, $0.01 Par Value 4,138 Indirect 401k
Reported Derivative Holdings
Sec. Name Sec. Type Price Date Expiration Date Amount Remaning Holdings Nature of Ownership
Common Stock Stock Option (to acquire Common Stock) $2.98 2023-03-24 2027-03-24 87,500 87,500 Direct
Common Stock Stock Option (to acquire Common Stock) $3.36 2023-02-11 2027-02-11 87,500 87,500 Direct
Common Stock Stock Option (to acquire Common Stock) $2.63 2022-01-11 2026-01-11 55,400 55,400 Direct
Common Stock Stock Option (to acquire Common Stock) $2.20 2021-02-24 2025-02-24 55,400 55,400 Direct
Expiration Date Amount Remaning Holdings Nature of Ownership
2027-03-24 87,500 87,500 Direct
2027-02-11 87,500 87,500 Direct
2026-01-11 55,400 55,400 Direct
2025-02-24 55,400 55,400 Direct
Footnotes
  1. Represents shares held by David Bench Consulty Group, a profit sharing plan of which the reporting person is a participant.
  2. Represents restricted shares granted subject the Company's discretionary matching contribution and non-elective employer contribution which vest ratable over four years of service, which began on December 23, 2019.
  3. The stock options have a five-year term and will vest in three equal instalments, one on the first anniversary of the grant date, the second on the second anniversary of the grant date and the third on the third anniversary of the grant date.